Changes

no edit summary
Line 362: Line 362:  
| [[FOXO3]] || 6q21 || [[AL]] || [[KMT2A]]
 
| [[FOXO3]] || 6q21 || [[AL]] || [[KMT2A]]
 
|-
 
|-
| [[FOXO4]] || Xq13.1 || [[AL]] || [[KMT2A]]
   
| [[FOXO4]] || Xq13.1 || [[soft tissue sarcoma]] || [[CIC]]
 
| [[FOXO4]] || Xq13.1 || [[soft tissue sarcoma]] || [[CIC]]
 
|-
 
|-
 +
| [[FOXO4]] || Xq13.1 || [[AL]] || [[KMT2A]]
 
|-
 
|-
 
| [[FOXP1]] || 3p14.1 || [[ALL]] || [[PAX5]]
 
| [[FOXP1]] || 3p14.1 || [[ALL]] || [[PAX5]]
Line 514: Line 514:  
| [[KLK2]] || 19q13.41 || [[prostate]] || [[ETV4]]
 
| [[KLK2]] || 19q13.41 || [[prostate]] || [[ETV4]]
 
|-
 
|-
| [[KMT2A]] || 11q23 || [[AML]],[[ALL]] || [[KMT2A]],[[MLLT1]],[[AFF1]],[[MLLT3]],[[MLLT4]],[[FOXO4]],[[MLLT10]],[[MLLT6]],[[ELL]],[[EPS15]],[[MLLT11]],[[CREBBP]],[[SH3GL1]],[[FNBP1]],[[SEPT5]],[[SEPT9]],[[GPHN]],[[GMPS]],[[ABI1]],[[ARHGEF12]],[[GAS7]],[[FOXO3]],[[AFF3]],[[TET1]],[[SEPT6]],[[LPP]],[[RUNX1T1]],[[ARHGAP26]],[[EP300]],[[PICALM]],[[CLP1]],[[PRRC1]],[[DAB2IP]],[[MAPRE1]],[[KIAA1524]],[[SEPT2]],[[SARNP]],[[ZFYVE19]],[[TOP3A]],[[CASC5]],[[EEFSEC]],[[FRYL]],[[SORBS2]],[[ABI2]],[[LASP1]],[[CASP8AP2]],[[AFF4]],[[NRIP3]],[[NCKIPSD]],[[CBL]],[[ACTN4]],[[PDS5A]],[[CT45A2]],[[MYO1F]],[[KIAA0284]],[[BTBD18]]
+
| [[KMT2A]] || 11q23 || [[AML]],[[ALL]] || [[KMT2A Partner Genes|Various KMT2A Partner Genes]]
 
|-
 
|-
 
| [[KMT2C]] || 7q36.1 || [[medulloblastoma]] ||   
 
| [[KMT2C]] || 7q36.1 || [[medulloblastoma]] ||